Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSCOPENHAGEN, DENMARK – September 29, 2021 – Nationalt Genom Center har indgået en aftale med IQVIA i Danmark om udvikling, leverance og implementering af et laboratorie- og informationssystem (LIMS). Kontrakten blev vundet af IQVIA efter en udbudsproces på mere end et år.
Systemet, der håndterer genomer fra patienter med henblik på at udvikle skræddersyede behandlinger, er udviklet af IQVIAs partner Sapio Sciences, der er en internationalt førende udbyder af laboratoriesystemer. IQVIA Danmark står for at levere konsulentydelser i en kontraktperiode, der løber over fire år.
Trækker på internationale erfaringer med genomer
IQVIA samarbejder allerede med Genomics England. Viden fra dette samarbejde, i kombination med mange års erfaring fra den danske sundhedssektor og kompetencer med at analysere data, danner et godt fundament for at udnytte de muligheder, der ligger i at anvende genomiske data. Kenneth Mikkelsen, General Manager IQVIA Denmark, uddyber:
”Vi har i mere end 25 år samarbejdet med den danske sundhedssektor og blandt vores kunder er flere hospitaler og nationale sundhedsaktører. Vi er meget glade for at udvide vores fodfæste med en organisation som Nationalt Genom Center, der er på en ekstremt interessant rejse, som er afgørende for at fremskynde innovative behandlinger af patienter og udviklingen af personlig medicin.”
IQVIA ønsker at gøre en forskel i sundhedsvæsenet og et strategisk samarbejde som dette partnerskab med Nationalt Genom Center og Sapio Sciences er en milepæl i forhold til arbejdet med at i fremme af patientbehandling gennem bedre forebyggelse, tidligere diagnose og mere målrettet behandling af patienter i Danmark.
“Sapio er meget glad for at samarbejde med IQVIA omkring dette vigtige initiativ som det danske Nationale Genom Center har iværksat. Den analytiske og intelligente tilgang, som har præget udvælgelsen af leverandører, udmærker sig ved at leverandører skal bevise, at de kan opfylde vigtige krav ved at vise evner i stedet for blot at beskrive dem, siger Kevin Cramer, chefforsker ved Sapio Videnskaber. Han tilføjer: "IQVIA gør et godt stykke arbejde, og vi ser frem til at arbejde tæt sammen med dem fremover."
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
About Sapio Sciences
Since 2007, Sapio Sciences has been a leading provider of LIMS, ELN and Scientific Data Management software enabling our customers to manage their laboratories, experiments, and scientific data efficiently and effectively.
Exemplar LIMS and ELN break new ground by providing a unified, science aware platform that also embodies integrated search and analytics, all reachable through its high performance, web-based user interface. Exemplar is in use at most of the world’s largest pharmaceutical companies a as well as leading diagnostic organizations.
Sapio has customers around the world. They include: BMS, AbbVie, GSK, Roche, Novartis, Baylor College of Medicine, Daichi Sanko, Sanofi and numerous other leading life sciences organizations.
Andrew Markwick, IQVIA Investor Relations (andrew.markwick@iqvia.com)
+1.973.257.7144
Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)
+1.484.567.6732
Anmarie Hazelton Sapio Sciences (ahazelton@sapiosciences.com)
+1.717.880.1265